About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Papuan Indigenous Model of Male Circumcision | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT06212531

Papuan Indigenous Model of Male Circumcision

The purpose of the study is: AIM 1: To engage Papuan community members to explore acceptability, barriers and facilitators for introducing a school-based age and culturally appropriate, comprehensive ...

Lead sponsor: University of Illinois at Chicago•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Illinois at Chicago

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)
Atma Jaya Catholic University of Indonesia

Age

15 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Resident of either Nabiri or Jayapura Districts of Papua, Indonesia. Able to provide informed consent if over 17 and parental consent and personal assent if less than 18.
•Focus group and interview participants had to be either a parent, boy or girl between 12-18, teacher or administrator, or community leader.
•To be eligible for circumcision, a boy had to be uncircumcised, age 15 years or above, and not show signs or symptoms of an STI or any penile abnormality (e.g., hypospadias, phimosis) that made him clinically ineligible for circumcision.

Exclusion Criteria

•Unable to provide informed consent or assent. Any medical condition indicating should not undergo circumcision.

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805 · HIV Infections

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047 · HIV, HIV Infections

WiseApp for Spanish Speakers Living With HIV

NCT05398185 · HIV Infections, Acquired Immune Deficiency Syndrome, and more

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT07428330 · Cervix Cancer, HIV Infections, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 19, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment239

Start dateSep 2020

Last updatedJan 19, 2024

Condition

Locations shown

University of Illinois Chicago, School of Public Health

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 19, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions